Group One Trading Reduces $677K in Abeona Therapeutics Inc. ($ABEO)
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Group One Trading reduced its position in Abeona Therapeutics Inc. ($ABEO) by 35.30% during the most recent quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 209,607 shares of Abeona Therapeutics Inc. after selling 114,379 shares during the quarter. Group One Trading's holdings in Abeona Therapeutics Inc. were worth $1.24 million as of its most recent filing.
Abeona Therapeutics Inc. Stock Down 0.1%
Shares of Abeona Therapeutics Inc. ($ABEO) traded around $5.92 on Saturday, down 0.1% for the day.
Abeona Therapeutics Inc. Earnings
Analysts Set New Price Targets
About Abeona Therapeutics Inc.
Abeona Therapeutics Inc., a commercial-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases in the United States. It develops ZEVASKYN, an autologous, cell-based gene therapy for the treatment of patients with recessive dystrophic epidermolysis bullosa. The company also develops ABO-503 to treat X-linked retinoschisis; ABO-504 for the treatment of stargardt disease; and ABO-505 to treat autosomal dominant optic atrophy. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was founded in 1974 and is headquartered in Cleveland, Ohio.
Get Abeona Therapeutics Inc. alerts
New 13F filings, insider trades, and analyst moves on $ABEO, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.